BRCA2 and neoplasm: As expected, a diagnosis of TNBC versus any other tumor subtype was more frequent among patients with pathogenic variants in BRCA1 than among patients with no pathogenic variant in BRCA1, BRCA2, or PALB2, both for AA patients and for EA patients (Table 4), although given small numbers, the association for all patients was significant only by log-linear analysis, adjusting for ancestry and age.